266 related articles for article (PubMed ID: 1565479)
1. A retrovirus that expresses v-abl and c-myc oncogenes rapidly induces plasmacytomas.
Largaespada DA; Kaehler DA; Mishak H; Weissinger E; Potter M; Mushinski JF; Risser R
Oncogene; 1992 Apr; 7(4):811-9. PubMed ID: 1565479
[TBL] [Abstract][Full Text] [Related]
2. Nonrandom chromosomal change (trisomy 11) in murine plasmacytomas induced by an ABL-MYC retrovirus.
Wiener F; Coleman A; Mock BA; Potter M
Cancer Res; 1995 Mar; 55(5):1181-8. PubMed ID: 7867005
[TBL] [Abstract][Full Text] [Related]
3. v-myc and v-raf act synergistically to induce B-cell tumors in pristane-primed adult BALBC mice.
Kurie JM; Morse HC; Principato MA; Wax JS; Troppmair J; Rapp UR; Potter M; Mushinski JF
Oncogene; 1990 Apr; 5(4):577-82. PubMed ID: 2183159
[TBL] [Abstract][Full Text] [Related]
4. Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice.
Wang Y; Sugiyama H; Axelson H; Panda CK; Babonits M; Ma A; Steinberg JM; Alt FW; Klein G; Wiener F
Oncogene; 1992 Jun; 7(6):1241-7. PubMed ID: 1375720
[TBL] [Abstract][Full Text] [Related]
5. ABL-MYC retroviral infection elicits bone marrow plasma cell tumors in Bcl-X(L) transgenic mice.
Linden M; Kirchhof N; Kvitrud M; Van Ness B
Leuk Res; 2005 Apr; 29(4):435-44. PubMed ID: 15725478
[TBL] [Abstract][Full Text] [Related]
6. Interaction of abl and raf with IL-7 signaling pathway and transformation of pre-B cells from resistant mice.
Hilbert DM; Theisen PW; Rudikoff EK; Bauer SR
Oncogene; 1998 Oct; 17(16):2125-35. PubMed ID: 9798684
[TBL] [Abstract][Full Text] [Related]
7. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
[TBL] [Abstract][Full Text] [Related]
8. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.
Cleveland JL; Jansen HW; Bister K; Fredrickson TN; Morse HC; Ihle JN; Rapp UR
J Cell Biochem; 1986; 30(3):195-218. PubMed ID: 3084503
[TBL] [Abstract][Full Text] [Related]
9. The transgenic window on lymphoid malignancy.
Adams JM; Harris AW; Vaux DL; Alexander WS; Rosenbaum H; Klinken SP; Strasser A; Bath ML; McNeall J; Cory S
Princess Takamatsu Symp; 1989; 20():297-309. PubMed ID: 2518688
[TBL] [Abstract][Full Text] [Related]
10. Addition of constitutive c-myc expression to Abelson murine leukemia virus changes the phenotype of the cells transformed by the virus from pre-B-cell lymphomas to plasmacytomas.
Weissinger EM; Mischak H; Goodnight J; Davidson WF; Mushinski JF
Mol Cell Biol; 1993 Apr; 13(4):2578-85. PubMed ID: 8455630
[TBL] [Abstract][Full Text] [Related]
11. Characterization of lymphoid tumors induced by a recombinant murine retrovirus carrying the avian v-myc oncogene. Identification of novel (B-lymphoid) tumors in the thymus.
Brightman BK; Chandy KG; Spencer RH; Gupta S; Pattengale PK; Fan H
J Immunol; 1988 Oct; 141(8):2844-54. PubMed ID: 2902139
[TBL] [Abstract][Full Text] [Related]
12. Induction of plasmacytomas secreting antigen-specific monoclonal antibodies with a retrovirus expressing v-abl and c-myc.
Weissinger EM; Mischak H; Largaespada DA; Kaehler DA; Mitchell T; Smith-Gill SJ; Risser R; Mushinski JF
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8735-9. PubMed ID: 1924333
[TBL] [Abstract][Full Text] [Related]
13. [Chromosome translocations and the activation of C-myc oncogene in mouse plasmacytomas].
Ohno S
Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):587-96. PubMed ID: 6424577
[TBL] [Abstract][Full Text] [Related]
14. Molecular requirements for rapid plasmacytoma and pre-B lymphoma induction by Abelson murine leukemia virus in myc-transgenic mice.
Sugiyama H; Wang Y; Jackson P; Sawyers CL; Klein G
Int J Cancer; 1994 Jul; 58(1):135-41. PubMed ID: 8014009
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of v-abl uniquely cooperates with c-myc dysregulation in induction of plasma cell tumors, bypassing the need for T-lymphocytic help and overcoming T-lymphocytic interference.
Weissinger EM; Byrd LG; Henderson DW; Mushinski JF
Int J Cancer; 1996 Jul; 67(1):142-7. PubMed ID: 8690515
[TBL] [Abstract][Full Text] [Related]
16. Retroviral enhancer insertion 5' of c-myc in two translocation-negative mouse plasmacytomas upregulates c-myc expression to different extents.
Shaughnessy JD; Owens JD; Wiener F; Hilbert DM; Huppi K; Potter M; Mushinski JF
Oncogene; 1993 Nov; 8(11):3111-21. PubMed ID: 8414513
[TBL] [Abstract][Full Text] [Related]
17. Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus.
Dyall-Smith D; Cory S
Oncogene Res; 1988 May; 2(4):403-9. PubMed ID: 2840624
[TBL] [Abstract][Full Text] [Related]
18. An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene.
Rosenbaum H; Harris AW; Bath ML; McNeall J; Webb E; Adams JM; Cory S
EMBO J; 1990 Mar; 9(3):897-905. PubMed ID: 2155783
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of myc-related oncogene mRNA characterizes most BALB/c plasmacytomas induced by pristane or Abelson murine leukemia virus.
Mushinski JF; Bauer SR; Potter M; Reddy EP
Proc Natl Acad Sci U S A; 1983 Feb; 80(4):1073-7. PubMed ID: 6302668
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal translocations activating myc sequences and transduction of v-abl are critical events in the rapid induction of plasmacytomas by pristane and abelson virus.
Ohno S; Migita S; Wiener F; Babonits M; Klein G; Mushinski JF; Potter M
J Exp Med; 1984 Jun; 159(6):1762-77. PubMed ID: 6202819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
